Vajir Malek

962 total citations
28 papers, 764 citations indexed

About

Vajir Malek is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Vajir Malek has authored 28 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 12 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Vajir Malek's work include Renin-Angiotensin System Studies (9 papers), Receptor Mechanisms and Signaling (4 papers) and Pancreatic function and diabetes (4 papers). Vajir Malek is often cited by papers focused on Renin-Angiotensin System Studies (9 papers), Receptor Mechanisms and Signaling (4 papers) and Pancreatic function and diabetes (4 papers). Vajir Malek collaborates with scholars based in India and United States. Vajir Malek's co-authors include Anil Bhanudas Gaikwad, Nisha Sharma, Almesh Kadakol, Anuradha Pandey, Santosh Kumar Goru, Kulbhushan Tikoo, Pinakin Arun Karpe, Sandeep Kumar, K. K. Srinivasan and Shrikant R. Mulay and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Vajir Malek

27 papers receiving 760 citations

Peers

Vajir Malek
Vajir Malek
Citations per year, relative to Vajir Malek Vajir Malek (= 1×) peers Despina Tsorotes

Countries citing papers authored by Vajir Malek

Since Specialization
Citations

This map shows the geographic impact of Vajir Malek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vajir Malek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vajir Malek more than expected).

Fields of papers citing papers by Vajir Malek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vajir Malek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vajir Malek. The network helps show where Vajir Malek may publish in the future.

Co-authorship network of co-authors of Vajir Malek

This figure shows the co-authorship network connecting the top 25 collaborators of Vajir Malek. A scholar is included among the top collaborators of Vajir Malek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vajir Malek. Vajir Malek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanwar, Vinay Singh, Marpadga A. Reddy, Vajir Malek, et al.. (2025). Palmitic acid alters enhancers/super-enhancers near inflammatory and efferocytosis-associated genes in human monocytes. Journal of Lipid Research. 66(4). 100774–100774. 1 indexed citations
2.
Abdollahi, Maryam, Vajir Malek, Vinay Singh Tanwar, et al.. (2025). Metabolic beneficial effects of targeting a long non-coding RNA, lnc-megacluster, in obesity. Molecular Therapy — Nucleic Acids. 37(1). 102792–102792.
3.
Chen, Zhuo, Vajir Malek, & Rama Natarajan. (2024). Update: the role of epigenetics in the metabolic memory of diabetic complications. American Journal of Physiology-Renal Physiology. 327(3). F327–F339. 6 indexed citations
4.
Kato, Mitsuo, Maryam Abdollahi, Keiko Omori, et al.. (2024). Lowering an ER stress-regulated long noncoding RNA protects mice from diabetes and isolated pancreatic islets from cell death. Molecular Therapy — Nucleic Acids. 35(3). 102252–102252. 3 indexed citations
5.
Tanwar, Vinay Singh, Marpadga A. Reddy, Sadhan Das, et al.. (2023). Palmitic Acid–Induced Long Noncoding RNA PARAIL Regulates Inflammation via Interaction With RNA-Binding Protein ELAVL1 in Monocytes and Macrophages. Arteriosclerosis Thrombosis and Vascular Biology. 43(7). 1157–1175. 12 indexed citations
6.
Malek, Vajir, Sachin V. Suryavanshi, Nisha Sharma, et al.. (2020). Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!. Reviews of physiology, biochemistry and pharmacology. 179. 31–71. 29 indexed citations
7.
Malek, Vajir, Nisha Sharma, & Anil Bhanudas Gaikwad. (2019). Simultaneous inhibition of neprilysin and activation of ACE2 prevented diabetic cardiomyopathy. Pharmacological Reports. 71(5). 958–967. 17 indexed citations
8.
Sharma, Nisha, Vajir Malek, Shrikant R. Mulay, & Anil Bhanudas Gaikwad. (2019). Angiotensin II type 2 receptor and angiotensin-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic rats. Life Sciences. 235. 116796–116796. 30 indexed citations
9.
Kadakol, Almesh, Santosh Kumar Goru, Vajir Malek, & Anil Bhanudas Gaikwad. (2017). Esculetin ameliorates vascular perturbation by intervening in the occupancy of H2BK120Ub at At1, At2, Tgfβ1 and Mcp1 promoter gene in thoracic aorta of IR and T2D rats. Biomedicine & Pharmacotherapy. 95. 1461–1468. 12 indexed citations
10.
Malek, Vajir & Anil Bhanudas Gaikwad. (2017). Neprilysin inhibitors: A new hope to halt the diabetic cardiovascular and renal complications?. Biomedicine & Pharmacotherapy. 90. 752–759. 32 indexed citations
11.
Kadakol, Almesh, et al.. (2017). Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications. Indian Journal of Pharmacology. 49(5). 348–348. 15 indexed citations
12.
Goru, Santosh Kumar, Almesh Kadakol, Vajir Malek, et al.. (2017). Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes. British Journal of Pharmacology. 174(18). 3118–3130. 65 indexed citations
13.
Karpe, Pinakin Arun, et al.. (2016). Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model. Toxicology and Applied Pharmacology. 306. 17–26. 51 indexed citations
14.
Pandey, Anuradha, Santosh Kumar Goru, Almesh Kadakol, et al.. (2016). H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats. Biochimie. 131. 68–76. 21 indexed citations
15.
Goru, Santosh Kumar, Almesh Kadakol, Anuradha Pandey, et al.. (2016). Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis. Biochemical Journal. 473(21). 3937–3949. 37 indexed citations
16.
Kadakol, Almesh, et al.. (2015). Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia. Biochemical and Biophysical Research Communications. 461(2). 342–347. 34 indexed citations
17.
Malek, Vajir, et al.. (2015). NFAT inhibitor tributylhexadecylphosphoniumbromide, ameliorates high fructose induced insulin resistance and nephropathy. Chemico-Biological Interactions. 240. 268–277. 5 indexed citations
18.
Kadakol, Almesh, Anuradha Pandey, Santosh Kumar Goru, Vajir Malek, & Anil Bhanudas Gaikwad. (2015). Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis. European Journal of Pharmacology. 765. 591–597. 13 indexed citations
19.
Pandey, Anuradha, et al.. (2015). Nanoparticles: A Neurotoxicological Perspective. CNS & Neurological Disorders - Drug Targets. 14(10). 1317–1327. 8 indexed citations
20.
Tikoo, Kulbhushan, et al.. (2014). Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications. Biochemical Pharmacology. 93(3). 343–351. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026